CRYSTALSFIRST

Pharmaceutical preparations for the treatment and prophylaxis of cardiovascular, auto-immunogenic, degenerative, gastric, neurological, neurodegenerative, neuro-inflammatory, pulmonary, and metabolic diseases; Pharmaceutical preparations for the treatment and prophylaxis of infections and diseases by a bacterial, viral, parasitical or fungal agent; Pharmaceutical preparations for the treatment and prophylaxis of rare diseases; Pharmaceutical preparations for the treatment and prophylaxis of geriatric diseases and disorders; Pharmaceutical preparations for the treatment and prophylaxis of psychiatric disorders; Pharmaceutical preparations for the purpose of specific complex formation and binding with target molecules for analytical and therapeutic purposes, for diagnostic purposes, for activating or inactivating a biological response, for drug targeting and target inactivation or activation, namely, in vitro generated or optimized enzymes, ribozymes, peptides, proteins, and small molecules of molecular weight below 500 and below 300

Scientific research; Scientific laboratory services; Research and development of new products for others; Chemical research